EcoDrugPlus

Ribosomal Protein L38

Ensembl ID : ENSSFOG00015018340
Gene Symbol: RPL38
3 Cross references
200 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSSFOG00015024033
Gene Symbol: RPL4
3 Cross references
344 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSSFOG00015020591
Gene Symbol: RPL5
1 Cross references
483 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSSFOG00015016589
Gene Symbol: RPL6
3 Cross references
486 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSSFOG00015000158
Gene Symbol: RPL7
3 Cross references
492 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSSFOG00015029564
Gene Symbol: RPL7A
3 Cross references
369 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSSFOG00015022286
Gene Symbol: RPL8
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSSFOG00015012147
Gene Symbol: RPL9
1 Cross references
509 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSSFOG00015019200
Gene Symbol: RPS10
3 Cross references
379 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSSFOG00015004554
Gene Symbol: RPS11
1 Cross references
286 Possible Orthologues:

Ribosomal Protein S12

Ensembl ID : ENSSFOG00015017146
Gene Symbol: RPS12
3 Cross references
290 Possible Orthologues:

Ribosomal Protein S13

Ensembl ID : ENSSFOG00015012346
Gene Symbol: RPS13
3 Cross references
290 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).